Hatch BioFund Announces New Partnership with Brandywine Realty Trust <<more here>>

News Releases and Coverage


March 1, 2024

PROTAC” modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitro - The authors are Blumberg Institute scientists and colleagues at the University of North Carolina.

Jan. 26, 2024

Pennsylvania Biotechnology Center to support promising life sciences startups through its new Academic Innovation Zone program

Jan. 5, 2024

Blumberg Institute presents 2023 Lam Excellence in Medicinal Chemistry Award



Dec. 20, 2023

Hatch BioFund Announces New Partnership with Brandywine Realty Trust

Dec. 7, 2023

Pennsylvania couple to receive Hepatitis B Foundation’s Community Leadership Award

Oct. 19, 2023

Jim Greenwood, former Congressman, ex-CEO of the world’s top biotech industry association, honored at the Pennsylvania Biotechnology Center

Oct. 5, 2023

Blumberg Institute salutes Nobel Prize winners Katalin Kariko and Drew Weissman

Sept. 26, 2023

Capital Health Awarded NIH Funding for Bladder Cancer Detection Study

Sept. 19, 2023

Blumberg Professor Nicholas Meanwell chosen for top award by the International Society for Antiviral Research

Aug. 1, 2023

Drug development journal publishes special issue to honor Nicholas Meanwell, Distinguished Professor at the Baruch S. Blumberg Institute

May 24, 2023

Robert Christmas, local bank executive, named Chief Operating Officer of the Hepatitis B Foundation, Blumberg Institute and Pennsylvania Biotechnology Center

May 9, 2023

The Wistar Institute, Pennsylvania Biotechnology Center and Baruch S. Blumberg Institute Forge Strategic Collaboration to Support Regional Biotech Startups

March 22, 2023

MERLIN BIOTECH  reveals  Novel Cancer Immunotherapy at Biotech Showcase ™ 2023

Jan. 17, 2023

Blumberg Institute awarded federal research contract worth up to $32 million to develop treatment for yellow fever

Jan. 8, 2023

Pennsylvania Biotechnology Center in Doylestown is epicenter of startups, investment



Dec. 22, 2022

Blumberg Institute presents 2022 Lam Excellence in Medicinal Chemistry Award

Nov. 29, 2022

The Blumberg Institute receives Angel Investment state funding thanks to Sen. Pat Browne 

Nov. 4, 2022

MERLIN Biotech CEO to present at BioFuture Nov. 8

Oct. 28, 2022

Blumberg Institute launches certificate program in Pharmaceutical Research & Development

Oct. 13, 2022

Blumberg spinout wins pitch competition at Biotech Week Boston

Aug. 22, 2022

Buckingham man's liver cancer battle inspires new research lab. 'No other family should suffer'

Aug. 11, 2022

Blumberg Institute Laboratory dedicated to liver cancer research in memory of Johnson & Johnson Consumer Inc. manager, a Doylestown-area resident

June 21, 2022

Randall N. Hyer, MD, PhD, MPH, former Moderna executive, named president of the Baruch S. Blumberg Institute

April 22, 2022

Baruch S. Blumberg Institute launches MERLIN Biotech, a spinout company leveraging mRNA technology for therapeutics and vaccines

February 22, 2022

International society elects Blumberg Institute scientist as board secretary

February 2, 2022

Randall N. Hyer, MD, PhD, MPH, joins the Blumberg Institute faculty